NASDAQ:CLBS
$3.55
(
1.14%
)
Friday, 27th Jan 2023
Caladrius Biosciences Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.90 | $4.87 | Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55. |
| 90 days | $2.90 | $4.87 | |
| 52 weeks | $0.402 | $9.75 |
Historical Caladrius Biosciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $3.50 | $3.55 | $3.50 | $3.55 | 0 |
| 2023-01-26 | $3.60 | $3.60 | $3.51 | $3.51 | 0 |
| 2023-01-25 | $3.66 | $3.71 | $3.56 | $3.63 | 0 |
| 2023-01-24 | $3.61 | $3.81 | $3.61 | $3.71 | 0 |
| 2023-01-23 | $3.50 | $3.68 | $3.50 | $3.64 | 0 |
| 2023-01-20 | $3.40 | $3.57 | $3.40 | $3.49 | 0 |
| 2023-01-19 | $3.38 | $3.50 | $3.38 | $3.49 | 0 |
| 2023-01-18 | $3.63 | $3.63 | $3.47 | $3.47 | 0 |
| 2023-01-17 | $3.64 | $3.67 | $3.50 | $3.62 | 0 |
| 2023-01-13 | $3.53 | $3.70 | $3.53 | $3.65 | 0 |
| 2023-01-12 | $3.21 | $3.65 | $3.21 | $3.58 | 0 |
| 2023-01-11 | $3.19 | $3.20 | $3.11 | $3.20 | 0 |
| 2023-01-10 | $3.00 | $3.20 | $3.00 | $3.20 | 0 |
| 2023-01-09 | $2.92 | $3.03 | $2.90 | $3.00 | 0 |
| 2023-01-06 | $2.99 | $3.02 | $2.97 | $3.00 | 0 |
| 2023-01-05 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2023-01-04 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2023-01-03 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-30 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-29 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-28 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-27 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-23 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-22 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-21 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-20 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-19 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-16 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-15 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-14 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-13 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-12 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-09 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-08 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-07 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-06 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-05 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-02 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-12-01 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-30 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-29 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-28 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-25 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-23 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-22 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-21 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-18 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-17 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-16 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
| 2022-11-15 | $4.87 | $4.87 | $4.87 | $4.87 | 0 |
About Caladrius Biosciences
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
